Prospect of generic asthma drug Advair hits Glaxo – Philly.com


The West Australian

Prospect of generic asthma drug Advair hits Glaxo
Philly.com
GlaxoSmithKline P.L.C.'s top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue, but generic competition got a bit closer to reality this week. Advair is delivered to patients through an inhaler
Mylan shares jump after FDA lays out guidelines for asthma genericMarketWatch (blog)
FDA Offers Guidance for Advair KnockoffsWall Street Journal
Glaxo May Face Generic Advair Sooner Than ExpectedForbes
Chicago Tribune –PMLiVE –FiercePharma
all 24 news articles »

View full post on asthma – Google News

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a … – 7thSpace Interactive (press release)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a
7thSpace Interactive (press release)
There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological features, including inflammation, smooth muscle contraction and remodeling.

View full post on asthma – Google News